PathAI is an AI-powered precision pathology company that analyzes tissue slide images to support cancer diagnosis, biomarker quantification, and drug development, training and validating its models using data from over 15 million annotations contributed by a network of 450 pathologists. Its key features include AISight, a cloud-based digital pathology platform for managing slides and integrating AI tools; automated slide analysis for cancer detection and tissue classification; biomarker scoring for markers such as PD-L1 and HER2; and a suite of clinical trial services, including patient stratification and companion diagnostic development. It is designed for academic medical centers, large pathology labs, and biopharmaceutical companies running clinical trials, rather than individual practitioners or small labs, and it is not positioned as a low-cost tool for small private labs.
Leave a Reply